These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 12788832

  • 1. Hypertension and the cortisol-cortisone shuttle.
    Quinkler M, Stewart PM.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2384-92. PubMed ID: 12788832
    [Abstract] [Full Text] [Related]

  • 2. Apparent mineralocorticoid excess syndrome: an overview.
    Palermo M, Quinkler M, Stewart PM.
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):687-96. PubMed ID: 15761540
    [Abstract] [Full Text] [Related]

  • 3. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM.
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [Abstract] [Full Text] [Related]

  • 4. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB, Stewart PM.
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [Abstract] [Full Text] [Related]

  • 5. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
    Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CH.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
    [Abstract] [Full Text] [Related]

  • 6. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 7. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM, Whorwood CB, Walker BR.
    Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
    [Abstract] [Full Text] [Related]

  • 8. Cortisol metabolism in hypertension.
    Hammer F, Stewart PM.
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):337-53. PubMed ID: 16980198
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
    Edwards CR, Benediktsson R, Lindsay RS, Seckl JR.
    Steroids; 1996 Apr; 61(4):263-9. PubMed ID: 8733012
    [Abstract] [Full Text] [Related]

  • 11. Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.
    Carvajal CA, Gonzalez AA, Romero DG, González A, Mosso LM, Lagos ET, Hevia Mdel P, Rosati MP, Perez-Acle TO, Gomez-Sanchez CE, Montero JA, Fardella CE.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2501-7. PubMed ID: 12788846
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population.
    Quinkler M, Bappal B, Draper N, Atterbury AJ, Lavery GG, Walker EA, DeSilva V, Taylor NF, Hala S, Rajendra N, Stewart PM.
    Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):143-9. PubMed ID: 15134813
    [Abstract] [Full Text] [Related]

  • 13. Cortisol as a mineralocorticoid in human disease.
    Stewart PM.
    J Steroid Biochem Mol Biol; 1999 Mar 31; 69(1-6):403-8. PubMed ID: 10419018
    [Abstract] [Full Text] [Related]

  • 14. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug 31; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 15. Apparent mineralocorticoid excess syndromes.
    Shimojo M, Stewart PM.
    J Endocrinol Invest; 1995 Aug 31; 18(7):518-32. PubMed ID: 9221270
    [Abstract] [Full Text] [Related]

  • 16. Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants.
    Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Wood PJ, Nuutila M, Andersson S.
    J Clin Endocrinol Metab; 2003 Jan 31; 88(1):493-500. PubMed ID: 12519895
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM, Corrie JE, Shackleton CH, Edwards CR.
    J Clin Invest; 1988 Jul 31; 82(1):340-9. PubMed ID: 3164727
    [Abstract] [Full Text] [Related]

  • 19. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA.
    Rev Med Chil; 2000 Jan 31; 128(1):17-26. PubMed ID: 10883518
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.